http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2899581-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8f3fc0bcee25a1161415431ccb1faf7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
filingDate 2006-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_892a469900deb5243a03e43d31815d19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e546ab4580db3e33a016e1c1b8dc3c34
publicationDate 2007-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2899581-A1
titleOfInvention METHOD FOR ATOMIZING IOXILAN
abstract The invention relates to a process for the preparation of ioxilan of the formula 5- (N-2,3-dihydroxypropylacetamido) -2,4,6-triiodo-N- (2,3-dihydroxypropyl) -N '- (2-hydroxyethyl) isophthalamide , by atomization, and the improved product thus obtained. This process avoids a crystallization process and leads to an active ingredient having improved solubility.
priorityDate 2006-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0919540-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4954348-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454515022
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420122097
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161316935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491824
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6144
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73561
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53627726
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15115278
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423390483
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID807
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451317762
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3015637
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15115279
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25544
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19962668
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425188129
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453348542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22179027
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409768179
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3731
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7290
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419494900
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546899
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74445
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419573778
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501403
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3743
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8759
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419765613
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3730
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419514457
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID904
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420258048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447561645
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65492
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554831
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409768164

Total number of triples: 56.